136 related articles for article (PubMed ID: 15914206)
21. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
[TBL] [Abstract][Full Text] [Related]
22. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
Campbell MR; Nation PN; Andrew SE
Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
[TBL] [Abstract][Full Text] [Related]
23. DNA mismatch repair mediates protection from mutagenesis induced by short-wave ultraviolet light.
Borgdorff V; Pauw B; van Hees-Stuivenberg S; de Wind N
DNA Repair (Amst); 2006 Nov; 5(11):1364-72. PubMed ID: 16880010
[TBL] [Abstract][Full Text] [Related]
24. A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma.
Hirata K; Kanemitsu S; Nakayama Y; Nagata N; Itoh H; Ohnishi H; Ishikawa H; Furukawa Y;
Am J Gastroenterol; 2006 Jan; 101(1):193-6. PubMed ID: 16405554
[TBL] [Abstract][Full Text] [Related]
25. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation.
Fritzell JA; Narayanan L; Baker SM; Bronner CE; Andrew SE; Prolla TA; Bradley A; Jirik FR; Liskay RM; Glazer PM
Cancer Res; 1997 Nov; 57(22):5143-7. PubMed ID: 9371516
[TBL] [Abstract][Full Text] [Related]
26. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
[TBL] [Abstract][Full Text] [Related]
27. Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background.
Toft NJ; Curtis LJ; Sansom OJ; Leitch AL; Wyllie AH; te Riele H; Arends MJ; Clarke AR
Oncogene; 2002 Sep; 21(41):6299-306. PubMed ID: 12214270
[TBL] [Abstract][Full Text] [Related]
28. XPC lymphoblastoid cells defective in the hMutSalpha DNA mismatch repair complex exhibit normal sensitivity to UVC radiation and normal transcription-coupled excision repair of DNA cyclobutane pyrimidine dimers.
Kobayashi K; O'Driscoll M; Macpherson P; Mullenders L; Vreeswijk M; Karran P
DNA Repair (Amst); 2004 Jun; 3(6):649-57. PubMed ID: 15135732
[TBL] [Abstract][Full Text] [Related]
29. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint.
Marquez N; Chappell SC; Sansom OJ; Clarke AR; Court J; Errington RJ; Smith PJ
Oncogene; 2003 Oct; 22(48):7642-8. PubMed ID: 14576827
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the mismatch repair defect in the human lymphoblastoid MT1 cells.
Szadkowski M; Iaccarino I; Heinimann K; Marra G; Jiricny J
Cancer Res; 2005 Jun; 65(11):4525-9. PubMed ID: 15930269
[TBL] [Abstract][Full Text] [Related]
31. (CAG)(n)-hairpin DNA binds to Msh2-Msh3 and changes properties of mismatch recognition.
Owen BA; Yang Z; Lai M; Gajec M; Badger JD; Hayes JJ; Edelmann W; Kucherlapati R; Wilson TM; McMurray CT
Nat Struct Mol Biol; 2005 Aug; 12(8):663-70. PubMed ID: 16025128
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer in an MSH2 gene mutation carrier.
Westenend PJ; Schütte R; Hoogmans MM; Wagner A; Dinjens WN
Hum Pathol; 2005 Dec; 36(12):1322-6. PubMed ID: 16311127
[TBL] [Abstract][Full Text] [Related]
33. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
[TBL] [Abstract][Full Text] [Related]
34. Acceleration of lymphomagenesis in mismatch-repair deficient mice by exposure to genotoxic agents.
Jansen L; Claij N; Dekker M; van Klink Y; van der Valk M; van 't Wout K; te Riele H
Toxicol Lett; 2000 Mar; 112-113():245-50. PubMed ID: 10720738
[TBL] [Abstract][Full Text] [Related]
35. The effect of Msh2 knockdown on methylating agent induced toxicity in DNA glycosylase deficient cells.
Cooley N; Elder RH; Povey AC
Toxicology; 2010 Jan; 268(1-2):111-7. PubMed ID: 20025921
[TBL] [Abstract][Full Text] [Related]
36. Senescence-dependent MutS alpha dysfunction attenuates mismatch repair.
Chang IY; Jin M; Yoon SP; Youn CK; Yoon Y; Moon SP; Hyun JW; Jun JY; You HJ
Mol Cancer Res; 2008 Jun; 6(6):978-89. PubMed ID: 18567801
[TBL] [Abstract][Full Text] [Related]
37. No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer.
Tuupanen S; Karhu A; Järvinen H; Mecklin JP; Launonen V; Aaltonen LA
Oncogene; 2007 Apr; 26(17):2513-7. PubMed ID: 17043646
[TBL] [Abstract][Full Text] [Related]
38. Binding of MutS mismatch repair protein to DNA containing UV photoproducts, "mismatched" opposite Watson--Crick and novel nucleotides, in different DNA sequence contexts.
Hoffman PD; Wang H; Lawrence CW; Iwai S; Hanaoka F; Hays JB
DNA Repair (Amst); 2005 Aug; 4(9):983-93. PubMed ID: 15996534
[TBL] [Abstract][Full Text] [Related]
39. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
40. 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
Colussi C; Fiumicino S; Giuliani A; Rosini S; Musiani P; Macrí C; Potten CS; Crescenzi M; Bignami M
J Natl Cancer Inst; 2001 Oct; 93(20):1534-40. PubMed ID: 11604476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
